NewGenIvf Group Stock to Reverse Split on Monday, October 12th (NASDAQ:NIVF)

Shares of NewGenIvf Group Limited (NASDAQ:NIVF) are going to reverse split on the morning of Monday, October 12th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 11th.

NewGenIvf Group Stock Down 23.5%

Shares of NIVF traded down $0.02 during trading hours on Thursday, hitting $0.08. The stock had a trading volume of 18,737,952 shares, compared to its average volume of 8,170,449. The company’s fifty day moving average is $1.12 and its two-hundred day moving average is $6.93. NewGenIvf Group has a 52 week low of $0.06 and a 52 week high of $1,539.00.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings results on Wednesday, October 7th. The company reported ($13.32) earnings per share (EPS) for the quarter. The company had revenue of $0.96 million for the quarter. Equities research analysts anticipate that NewGenIvf Group will post 42.67 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

NIVF has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Friday, July 24th. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, NewGenIvf Group has a consensus rating of “Sell”.

Insider Buying and Selling at NewGenIvf Group

In related news, Director Kong Yiu Cheung bought 2,500,000 shares of NewGenIvf Group stock in a transaction dated Monday, July 27th. The shares were bought at an average cost of $1.00 per share, for a total transaction of $2,500,000.00. Following the completion of the transaction, the director owned 3,722,223 shares of the company’s stock, valued at approximately $3,722,223. This trade represents a 204.55% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing.